A study testing two targeted medicines, bomedemstat, which helps normalise blood cell development, and momelotinib, which reduces symptoms and anaemia, to see whether the combination is safe and effective for people with myelofibrosis

http://isrctn.com/ 2026 Dataset

View at publisher

Authors: Ciro Roberto Rinaldi

DOI: 10.1186/isrctn98283910

Cited by: 0

Fields of Study & Subjects

Myeloproliferative Neoplasms: Diagnosis and Treatment Acute Myeloid Leukemia Research Cutaneous lymphoproliferative disorders research